NCT00237913 - Schizophrenia Trial of Aripiprazole | Biotech Hunter

Enrollment

700

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

Schizophrenia

Interventions

DRUG

Aripiprazole

Tablets, Oral, 10 - 30 mg, Once daily, 26 weeks.

DRUG

Olanzapine or Quetiapine or Risperidone

Olanzapine: Tablets, Oral, 5-20 mg, Once daily, 26 weeks. OR Quetiapine: Tablets, Oral, 100-800 mg, Once daily, 26 weeks. OR Risperidone: Tablets, Oral, 2-8 mg, Once daily, 26 weeks.

Trial Locations (33)

Unknown

Local Institution, Vienna

Local Institution, Přerov

Local Institution, Copenhagen

Local Institution, Hørsholm

Local Institution, Helsinki

Local Institution, Brumath

Local Institution, Dole

Local Institution, Hénin-Beaumont

Local Institution, Jonzac

Local Institution, Nantes Orvault

Local Institution, Paris

Local Institution, Reims

Local Institution, Rennes

Local Institution, Toulouse

Local Institution, Uzès

Local Institution, Duisburg

Local Institution, Hattingen

Local Institution, München

Local Institution, Nuremberg

Local Institution, Oldenburg

Local Institution, Murcia

Local Institution, Bromma

Local Institution, Gothenburgh

Local Institution, Halmstad

Local Institution, Malmo

Local Institution, Säter

Local Institution, Belfast

Local Institution, London

Local Institution, Royal Tunbridge Wells

Local Institution, Glasgow

Local Institution, Davyhulme

Local Institution, South Wales

Local Institution, Birmingham